Concepedia

Faliang Xing

FX

Statistics

Publications

1

Citations

25

H-Index

1

Active since

2024

Affiliations

Fudan University Shanghai Cancer Center(Current)

Faliang Xing is an author at Fudan University Shanghai Cancer Center specializing in canonical wnt beta-catenin pathway, chemotherapy, and combination chemotherapy resistance.

Publications per year

2024–2024

1

Publications

1

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer

Borui Li, Faliang Xing, Jingyi Wang et al. · Cancer Letters · 2024 · 25 citations · Full text

, , +17

1–1 of 1